SYRINGE AND NEEDLE,

The contract solicits 3 mL, 20-gauge safety hypodermic syringes and needles, identified by NSN 6515-01-452-0408, with each unit packaged in quantities of 100 per package. The product must be sterile, disposable, non-toxic, and non-pyrogenic, featuring an automatic needle retraction mechanism that pulls the needle into the syringe barrel upon plunger depression to enhance user safety. Compliance with Regulation 880.5860 Class II is required, mandating FDA 510(k) clearance and adherence to labeling, registration, listing, and good manufacturing practices. The item falls under a non-extendable 60-month shelf life classification (Type I, Code S), and all packaging and marking must conform to Medical Marking Standard No. 1, replacing MIL-STD-129; units must be sealed in commercial-grade containers that protect against damage and be packed in suitable exterior shipping containers for safe, cost-effective delivery to APO 09227-0000. Delivery is required within 84 days after order placement under FOB Destination terms, with no quantity variance permitted. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, and all contractors must submit Safety Data Sheets and hazard warning labels for any hazardous materials, ensuring compliance with 29 CFR 1910.1200(g) and Federal Standard No. 313. The contract is subject to DFARS and FAR clauses addressing cybersecurity, including NIST SP 800-171 assessment mandates, prohibitions on hexavalent chromium and toxic material handling, export controls, trafficking in persons, employment eligibility verification, and sustainable product compliance, all reinforced by Deviation 2026-00038. Payment and receiving reporting must be submitted electronically via Wide Area Workflow, with invoice and receiving report combos required for fixed-price items. Contractors must maintain current SAM registrations, represent their socioeconomic status including small business or WOSB eligibility, and certify compliance with the Berry Amendment and Buy American Act. Offers including items produced via unauthorized additive manufacturing are ineligible for award, and the contract includes strict clauses on government identification removal from non-accepted supplies and restrictions on mandatory arbitration. The solicitation, issued under SPE2DS-26-T-111D with a response deadline of June 8